These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3798343)

  • 41. HBeAG and anti-HBe in the Malaysian population and in Malaysian prisoners.
    Ton SH; Lopez CG; Noriah R
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):252-4. PubMed ID: 6635764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 44. [Detecting HBeAg and anti-HBe by ELISA].
    Li CM; Liu CB; Zhang WY; Zhang MC; Li LW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):227-9. PubMed ID: 6241057
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic implications of HBeAg in hepatitis B infection.
    Sabău M; Kasza L; Makai M; Doble R
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):211-5. PubMed ID: 7332453
    [No Abstract]   [Full Text] [Related]  

  • 46. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
    Calzia R; Ciravegna B; Navone C; Tolentino P
    Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis].
    Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
    Ann Univ Mariae Curie Sklodowska Med; 1987; 42():89-94. PubMed ID: 3154901
    [No Abstract]   [Full Text] [Related]  

  • 48. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
    Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on the HBV carriers superinfected with HDV--influence of HDV superinfection on HBeAg/anti-HBe system and transaminase level].
    Tamura I; Ichimura H; Itoh Y; Kurimura O; Kurimura T
    Kansenshogaku Zasshi; 1988 Mar; 62(3):253-8. PubMed ID: 3147306
    [No Abstract]   [Full Text] [Related]  

  • 50. The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.
    Fiaccadori F; David S; Faggion G; Feriani N; Ferrari C; Franco V; Giuberti T; Grutta D'Auria C; La Greca G; Magnani G
    Infection; 1984; 12(1):23-6. PubMed ID: 6368400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of acute hepatitis due to virus B. Study of 92 cases].
    Vetencourt RJ; de Silva M; de Armas J; Betty G; Oropeza F
    G E N; 1988; 42(1):13-7. PubMed ID: 3152427
    [No Abstract]   [Full Text] [Related]  

  • 52. [New knowledge on persistent and latent hepatitis B virus infections].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1987; 81(18):931-2. PubMed ID: 3424877
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients.
    Liaw YF; Tai DI; Chu CM; Pao CC; Chen TJ
    Hepatology; 1987; 7(1):20-3. PubMed ID: 2433203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New HBeAg immune binding sites found by Mc-anti-HBe.
    Zhang Z; Li XF; Sun Y; Tao QM
    Chin Med J (Engl); 1988 Jul; 101(7):517-8. PubMed ID: 2465873
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group.
    Zarski JP; Marcellin P; Cohard M; Lutz JM; Bouche C; Rais A
    J Hepatol; 1994 May; 20(5):636-40. PubMed ID: 8071540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Relationship between serum HBeAg/anti-HBe and liver histologic finding or intrahepatic HBcAg in chronic type B hepatitis].
    Komatsu M; Tobori F; Yagisawa H; Mizuno Y; Arakawa H; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1987 Dec; 84(12):2700-5. PubMed ID: 3450884
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview.
    Bonino F; Brunetto MR
    J Hepatol; 2003; 39 Suppl 1():S160-3. PubMed ID: 14708696
    [No Abstract]   [Full Text] [Related]  

  • 58. [The retrospective analysis of the histological course by use of GPT integration value in anti HBe positive cases with abnormal GPT].
    Arase Y; Kumada H; Ikeda K; Nakamura I; Chayama K; Saito S; Gunji T; Murasima N; Takeuchi K; Nakajima M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Apr; 85(4):871-5. PubMed ID: 3404751
    [No Abstract]   [Full Text] [Related]  

  • 59. HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
    Tanno H; Fay OH; Rojman JA; Palazzi J; Bessone F
    J Med Virol; 1988 May; 25(1):45-51. PubMed ID: 3045258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [An adult case of HBV nephropathy with positive HBeAg on glomerular capillary wall after seroconversion to HBeAb in serum].
    Tanabe H; Mori M; Saito M; Kawai H; Hayashi M; Iriyama K; Ohashi M; Yamashina M; Onishi H; Moriwaki H
    Nihon Shokakibyo Gakkai Zasshi; 1990 Mar; 87(3):861-4. PubMed ID: 2388430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.